IL-10 levels and disease characteristics (n = 159)
| Category . | No. patients . | Median IL-10 (pg/mL) (range) . | P value3-150 . |
|---|---|---|---|
| β2-microglobulin (mg/L) | |||
| <2 | 30 | <3 (<3-42) | .001 |
| ≥2 | 112 | 6.60 (<3-70) | |
| Previous treatment | |||
| Yes | 91 | 3.27 (<3-64) | <.005 |
| No | 68 | 8.60 (<3-74) | |
| Serum LDH level (IU/mL)3-151 | |||
| ≥618 | 29 | 16.10 (<3-74) | .000002 |
| <618 | 112 | 4.43 (<3-55) | |
| Rai stage | |||
| 0, I, II | 131 | 4.29 (<3-64) | .001 |
| III, IV | 28 | 10.40 (<3-74) | |
| Age (y) | |||
| <60 | 84 | 4.57 (<3-74) | .068 |
| ≥60 | 75 | 6.81 (<3-70) |
| Category . | No. patients . | Median IL-10 (pg/mL) (range) . | P value3-150 . |
|---|---|---|---|
| β2-microglobulin (mg/L) | |||
| <2 | 30 | <3 (<3-42) | .001 |
| ≥2 | 112 | 6.60 (<3-70) | |
| Previous treatment | |||
| Yes | 91 | 3.27 (<3-64) | <.005 |
| No | 68 | 8.60 (<3-74) | |
| Serum LDH level (IU/mL)3-151 | |||
| ≥618 | 29 | 16.10 (<3-74) | .000002 |
| <618 | 112 | 4.43 (<3-55) | |
| Rai stage | |||
| 0, I, II | 131 | 4.29 (<3-64) | .001 |
| III, IV | 28 | 10.40 (<3-74) | |
| Age (y) | |||
| <60 | 84 | 4.57 (<3-74) | .068 |
| ≥60 | 75 | 6.81 (<3-70) |